You're reading the free version. Trader adds the live tape and alerts.
Start tracking
VERA Sale Disclosure
Fordyce Marshall · SEC Form 4 · Filed Jun 24, 2026
Sale
Calculated transaction value
$3.38K
Fordyce Marshall President And CEO
VERA
Vera Therapeutics
VERA
Transaction date
Jun 23, 2026
Public filing date
Jun 24, 2026
Filing lag
Filed 1 day later
VERA daily price context
Close on/before transaction
$38.2
Jun 23, 2026
First close after public filing
$40.5
Jun 25, 2026
30-day return after filing
-12.47%
Through Jul 24, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 88 shares @ $38.43
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001859453-26-000008
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$701.77K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vera Therapeutics, Inc. VERA | Sale | Jun 23, 2026 | $698.39K |
| Vera Therapeutics, Inc. VERA Current | Sale | Jun 23, 2026 | $3.38K |